*Press releases are taken from the company websites.
*Titles may be translated independently.
*Please be aware that, since data is collected automatically, there is a possibility of omissions occurring.
*We would like to kindly inform you that we do not collect all press releases from companies.
| Ticker Code | Date | Title | Link |
|---|---|---|---|
| TSE:2269 | 7/15/2025 | Bio-plastic tray made using cocoa husk for the first time in a commercially available product. A sustainable chocolate mold provides children with the opportunity to learn about the environment "Play! Learn! Sustainable Mushroom Mountain" 50th Anniversary | https://www.meiji.co.jp/corporate/pressrelease/2025/07_07/ |
| TSE:4540 | 7/15/2025 | Tsumura Ibaraki Factory groundbreaking ceremony to construct a new building | https://www.tsumura.co.jp/newsroom/newsrelease/item/20250715.pdf |
| TSE:4886 | 7/15/2025 | July 15th, 2025 Notice regarding the public recruitment of drug discovery research in 2025 308.87 KB | https://www.aska-pharma.co.jp/news/filedownload.php?name=37acd58380b16821411eaf55ca00e84e.pdf |
| TSE:4901 | 7/15/2025 | PFAS-free Negative ArF Immersion Resist Newly Developed (Fujifilm) | https://www.fujifilm.com/jp/ja/news/list/12568 |
| TSE:2269 | 7/14/2025 | Get through the extreme heat!A combination of slightly salty lemon sourness and yogurt makes it refreshing and refreshing on hot summer days. First appearance in a summer-only flavor "Meiji Bulgaria Frozen Yogurt Dessert Salt Lemon" New release on July 21 | https://www.meiji.co.jp/corporate/pressrelease/2025/07_09/ |
| TSE:2269 | 7/14/2025 | Participated in the "Two-industry Business Leadership School 2025", which is working to support diverse careers across industries in order to promote women's participation - Approximately 70 mid-school female employees from 13 companies will be participat | https://www.meiji.co.jp/corporate/pressrelease/2025/07_06/ |
| TSE:4516 | 7/14/2025 | Regarding receipt of notification of review completion report regarding application for biologics approval for CAP-1002 | https://www.nippon-shinyaku.co.jp/news/news.php?id=3415 |
| TSE:4569 | 7/14/2025 | Regarding the introduction of "number notification request" | https://www.kyorin-pharm.co.jp/news/2025/001841.shtml |
| TSE:4886 | 7/14/2025 | July 14, 2025 Notice of opening of "arca" community center at Asuka Pharmaceutical Co., Ltd. ZEB certified community center 481.66 KB | https://www.aska-pharma.co.jp/news/filedownload.php?name=4d5f31f45e4707c235e1321841a7cdc9.pdf |
| TSE:4901 | 7/14/2025 | Developed technology to generate and automatically create patient information documents using AI (Fujifilm) | https://www.fujifilm.com/jp/ja/news/list/12563 |
| AZN | 7/14/2025 | Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension | http://www.astrazeneca.com/media-centre/press-releases/2025/baxdrostat-met-primary-and-all-secondary-endpts-in-baxhtn-phiii-trial.html |
| MRK | 7/14/2025 | Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill | https://www.merck.com/news/merck-to-initiate-phase-3-trials-for-investigational-once-monthly-hiv-prevention-pill/ |
| TSE:4502 | 7/14/2025 | Good top-line results in two important phase 3 clinical trials of oveporexton (TAK-861) for narcolepsy type 1. Good top-line results in two important phase 3 clinical trials of oveporexton (TAK-861) for narcolepsy type 1. | https://www.takeda.com/jp/newsroom/newsreleases/2025/positive-results-phase-3-oveporexton-narcolepsy-type-1/ |
| TSE:4528 | 7/11/2025 | Added approval for the efficacy or effect of "first-line treatment of hepatocellular carcinoma with unresectable or distant metastasis" using Opdivo and Yervoy combination therapy in Korea | https://www.ono-pharma.com/ja/news/20250711.html |
| TSE:4530 | 7/11/2025 | Notice regarding the results of acquisition of treasury stock through an off-site purchase transaction (ToSTNeT-3) | https://www.hisamitsu.co.jp/company/pdf/news_release_250711.pdf |